Amgen Buys deCODE Genetics
Thousand Oaks-based biotech Amgen is acquiring Iceland-based deCODE Genetics, in a deal worth $415M in cash, the two companies announced this morning. deCODE Genetics is a provider of human genetic research which was founded in 1996. deCODE said its genetic research will help Amgen translate its discoveries into meaningful therapies for patients. deCODE Genetics has been using studies of the Icelandic population to help uncover the specific genes and genetic risk factors in diseases.
posted on Monday, December 10, 2012
Related companies:
Amgen Ventures
Related stories:
> deCODE, Illumina In DNA Alliance
> Amgen Buys Turkish Pharmaceutical Company
> Amgen Donates $1M For Japanese Disaster Relief
> Amgen Expands Board
> Amgen Spins Out Biotech Firm
socalTECH.com Home